Insulin Therapy Center

With this week’s Homerun Slides, we start a short new series on Insulin Resistance put together by Dr. Stanley Schwartz. We begin with a quick overview of the traditional view of the natural history of diabetes as compared to Dr. Schwartz’s newer beta-cell centric model…. To download the complete set …

This week’s Homerun Slides finishes up with a conversation on the newer formulations of long acting insulin and how they compare to insulin glargine U100…. To download the complete set in PowerPoint (.ppt) format just use this link: New Insulin Formulations – Umpierrez, Part 3 Other Homerun Slides sets in this …

In this week’s Homerun Slides, we review the properties of insulin glargine including U-300 glargine vs U-100 glargine. With the advent of Toujeo on the market, you may want to review these slides….

Sanofi hoping to convert patients to Toujeo as Lantus is due to lose U.S. patent protection.

In this week’s Homerun Slides, we begin a new series from Dr. Guillermo Umpierrez, Professor, Emory University School of Medicine, which will update you on the latest insulin developments, and also delve into exactly how these insulins differ in their effects…. To download the complete set in PowerPoint (.ppt) format …

A patient came to us on reasonably high doses of basal bolus insulin, using Levemir and NovoLog flex pens. He stated that he had been using insulin for a few months and was referred for more management assistance from his provider. He was seen by a CDE to review his …

David Levy, MD, FRCP Insulin Pump Treatment (CSII) First used at the end of the 1970s, insulin pump therapy is standard treatment for type 1 diabetes, although use varies between countries (e.g. about 1–2% in the UK, probably more now; about 25% in USA, up to 40% in Norway). Only rapid-acting …

A novel insulin that automatically adjusts blood sugar may mitigate some of the complications associated with insulin dosing for patients with type 1 diabetes… Self-administered insulin is the most important therapeutic to provide control over blood glucose levels for patients with type 1 diabetes. However, standard insulin therapy introduces a …

David Levy, MD, FRCP Introduction Insulin treatment in type 1 diabetes is substitution/replacement hormone treatment, but replacement is much more variable and difficult to achieve than in other hormone deficiencies (e.g. thyroid, adrenal, gonadal hormones) because of the minute-by-minute variation in insulin secretion by the intact pancreas, which cannot yet be …

Success in finding new stem cells that can produce insulin… Type 1 diabetes is caused by autoimmune disease that leads to the destruction of insulin producing beta cells in the pancreas. The destruction of beta cells in the pancreas can be treated by transplant of pancreatic beta cells or cadaveric …